SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending as investors discuss its potential as an AI automation leader, especially after recent partnerships with major tech companies. The community is drawing comparisons to Palantir ($PLTR) and anticipating a possible gamma squeeze, fueled by high short interest. Some are noting the stock's long consolidation period and suggesting a significant breakout may be imminent, while others are wary of its high P/E ratio.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ is trending due to a strategic partnership to develop quantum-resistant chips for defense applications, sparking excitement about potential U.S. government contracts. The community is actively discussing the implications of this partnership, potential short squeezes, and comparing LAES to other quantum and AI stocks. Many believe the stock is undervalued and poised for significant growth, referencing past rallies and revenue potential.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices surge, nearing multi-decade highs, driven by industrial demand and a weaker dollar. Community members are actively discussing whether this rally has staying power, with some predicting a short squeeze and significant upside potential. Concerns about potential manipulation and the decoupling of the ETF from spot prices are also being debated.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

AQST is trending due to increased visibility and optimism surrounding its drug Anaphylm, highlighted by a recent mention on Mad Money. The community is actively discussing the potential for FDA approval, the competitive landscape with $SPRY, and the possibility of a buyout. Bullish sentiment is fueled by the unique delivery method of Anaphylm and its potential to disrupt the epinephrine market.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics is trending following a strategic partnership announcement with DoorDash, sparking optimism about expanded autonomous delivery services. The community is actively discussing potential price targets and the impact of this deal on the company's revenue and growth. Some traders are also noting bullish technical indicators and increased call option activity.

Global Health Solutions Inc is an American company that works with partners to eliminate diseases that have plagued humanity for centuries and protect the health of populations by helping countries build strong health systems. The private company is located in the US. The company brings together key stakeholders around the world with a common goal to stop diseases and strengthen health systems through powerful partnerships. The company consists of programs and focus areas that cover a range of health issues including neglected tropical diseases, infectious diseases, vaccines, field epidemiology, public health informatics, health workforce development, and health ethics. The company's end goal is to eliminate diseases and protect the health of populations.

Turn Therapeutics Inc.

Turn Therapeutics Inc

Turn Therapeutics ($TTRX) is trending due to significant volatility following its recent IPO, with the community actively debating whether it will continue to surge or face a sharp correction. Bullish investors are hoping for a short squeeze reminiscent of similar biotech stocks, while bears anticipate a pullback given the company's valuation. The stock's high trading volume and price swings have fueled intense speculation and conflicting opinions.

GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The firm offers consumers free access to transparent and lower prices for brand and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information. The company was founded by Trevor Bezdek and Douglas Joseph Hirsch in September 2011 and is headquartered in Santa Monica, CA.

GoodRx Holdings Inc - Ordinary Shares - Class A

GoodRx Holdings Inc

GoodRx is trending amid discussions of a potential partnership with TrumpRx, with the community actively speculating on the deal's implications. News of retail pharmacies and GoodRx potentially being in talks with the Trump administration is driving interest. Some traders are pointing to the stock's history and potential for significant upside.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is trending due to a mix of factors, including news of OnePay launching wireless plans and a price target increase from Tigress Financial. While some traders express concerns about valuation and insider selling, others highlight Walmart's potential for AI-driven growth and defensive qualities in a recessionary environment. Community discussions also touch on technical analysis, potential pullbacks, and the stock's overall bullish momentum.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X ($CCCX) is trending as the community discusses its upcoming merger with Infleqtion, a quantum computing company, and its potential to outperform sector peers. Some are highlighting Infleqtion's existing contracts with the U.S. government, NASA, and NVIDIA, along with its comparatively lower valuation relative to competitors like $IONQ and $RGTI. Bullish sentiment is building, with many anticipating significant upside potential as the merger nears and Infleqtion gains more recognition.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is trending as the stock demonstrates a significant move, sparking excitement among investors who see potential for further gains. Community members are actively discussing potential breakouts, short squeezes, and the impact of broader market factors like interest rate cuts on the solar sector. Some investors believe the stock is undervalued compared to its peers, while others cite policy headwinds as a factor.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wolfe Research upgraded Otis Worldwide to “Outperform” from “Peer Perform,” citing improving new equipment orders and sales momentum that could drive a rebound in cash flow as 2025 comes to a close. 
The firm acknowledged lingering risks for Q4 forecasts and possible small cuts to 2026 consensus estimates but said these concerns are already priced into the stock. Wolfe sees room for sentiment to turn more positive as China’s market stabilizes and order momentum builds. 
Otis’s new equipment segment, pressured by weak construction in China and Europe, appears close to bottoming, while its service business remains steady. Wolfe believes stronger order and sales growth could restore mid-single-digit organic revenue gains and boost free cash flow conversion. 
The stock trades around 21 times forward earnings, below peers at 26–29 times, and Wolfe expects that valuation gap to narrow as growth improves. 
$OTIS

StockTwits Web

Otis Worldwide Corp

Wolfe Research upgraded Otis Worldwide to “Outperform” from “Peer Perform,” citing improving new equipment orders and sales momentum that could drive a rebound in cash flow as 2025 comes to a close. 
The firm acknowledged lingering risks for Q4 forecasts and possible small cuts to 2026 consensus estimates but said these concerns are already priced into the stock. Wolfe sees room for sentiment to turn more positive as China’s market stabilizes and order momentum builds. 
Otis’s new equipment segment, pressured by weak construction in China and Europe, appears close to bottoming, while its service business remains steady. Wolfe believes stronger order and sales growth could restore mid-single-digit organic revenue gains and boost free cash flow conversion. 
The stock trades around 21 times forward earnings, below peers at 26–29 times, and Wolfe expects that valuation gap to narrow as growth improves. 
